GO:0004385 GMP kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004385 (GMP kinase activity) catalyzes the reversible transfer of a phosphate group from ATP to GMP, yielding ADP and GDP, as defined by QuickGO.
• The term is synonymous with guanylate kinase activity, deoxyguanylate kinase activity, and 5'-GMP kinase activity, reflecting its broad nucleotide substrate range.
• GMP kinase activity is essential for maintaining cellular guanine nucleotide pools, which support DNA synthesis, RNA synthesis, and GTP-dependent signaling.
• Mutations in GUK1, the gene encoding guanylate kinase 1, cause a novel mitochondrial DNA depletion/deletions disease that is potentially treatable.
• Membrane-associated guanylate kinases (MAGUKs) are scaffold proteins that organize synaptic signaling complexes and are implicated in glutamatergic synapse function.
• CRISPR-based knockout, point-mutation, and knock-in models are powerful tools to dissect the role of GMP kinase activity in health and disease.
Description
GMP kinase activity (GO:0004385) is a fundamental enzymatic activity that catalyzes the phosphorylation of guanosine monophosphate (GMP) to guanosine diphosphate (GDP) using ATP as the phosphate donor. This reaction is a critical step in the salvage pathway of guanine nucleotide biosynthesis, ensuring adequate cellular levels of GDP and, subsequently, GTP, which are required for nucleic acid synthesis, protein synthesis, and signal transduction. The enzyme responsible for this activity, guanylate kinase 1 (GUK1 in humans), has been recently linked to a severe mitochondrial DNA depletion syndrome, underscoring its importance in human health. Beyond its canonical metabolic role, the guanylate kinase domain is a hallmark of membrane-associated guanylate kinases (MAGUKs), a family of scaffolding proteins that organize synaptic receptors and signaling complexes at cell junctions. Understanding GMP kinase activity is therefore essential for researchers studying nucleotide metabolism, mitochondrial biology, and synaptic function.
GMP kinase activity At A Glance
| GO ID | GO:0004385 |
|---|---|
| GO term | GMP kinase activity |
| Ontology | molecular_function |
| Synonym | guanylate kinase activity; deoxyguanylate kinase activity; 5'-GMP kinase activity; ATP:GMP phosphotransferase activity; membrane-associated guanylate kinase |
| Major function | Catalyzes the phosphorylation of GMP to GDP using ATP, contributing to guanine nucleotide homeostasis. |
| Reaction | ATP + GMP = ADP + GDP |
| Cellular context | Cytosol, mitochondria, and membrane-associated scaffolds (MAGUKs) |
| Associated gene | GUK1 (guanylate kinase 1) in humans |
| Disease relevance | Mitochondrial DNA depletion/deletions disease due to GUK1 deficiency |
What Is GO:0004385?
According to the Gene Ontology, GMP kinase activity (GO:0004385) is defined as the catalysis of the reaction: ATP + GMP = ADP + GDP. In other words, it is an enzyme activity that transfers a phosphate group from ATP to GMP, producing ADP and GDP. This activity is also known by several synonyms, including guanylate kinase activity, deoxyguanylate kinase activity, and 5'-GMP kinase activity, reflecting its ability to phosphorylate both ribo- and deoxyribonucleotides.
Why Is GMP kinase activity Important in Cell Biology?
GMP kinase activity is a cornerstone of nucleotide metabolism, directly influencing the cellular pools of GDP and GTP, which are indispensable for DNA replication, RNA transcription, and GTP-dependent signaling pathways. Its dysfunction has been linked to a newly described mitochondrial DNA depletion syndrome, highlighting its non-redundant role in mitochondrial genome maintenance. Furthermore, the guanylate kinase domain is a defining feature of MAGUK scaffold proteins, which are critical for synaptic development and plasticity, making GMP kinase activity a subject of intense interest in neuroscience. Thus, studying this activity bridges fundamental biochemistry with clinical and neurobiological research.
• Maintains cellular GTP pools required for DNA and RNA synthesis.
• Supports mitochondrial DNA replication and stability; GUK1 deficiency causes mtDNA depletion.
• Provides GDP for GTP-binding proteins and signal transduction.
• Essential for synaptic function via MAGUK scaffolding proteins.
• Implicated in a potentially treatable mitochondrial disease.
• Target for understanding guanine nucleotide salvage pathways.
• Relevant to cancer metabolism due to altered nucleotide pools.
• Modeled by CRISPR to study gene function and disease mechanisms.
What Happens During GMP kinase activity?
Substrate Binding and Phosphoryl Transfer
In simple terms: The enzyme grabs ATP and GMP, then hands a phosphate from ATP to GMP.
GMP kinase activity catalyzes the transfer of the gamma-phosphate of ATP to the 5'-hydroxyl group of GMP, forming GDP and ADP. This reaction is reversible and follows a sequential kinetic mechanism where both substrates must bind before catalysis. The enzyme preferentially uses ATP as the phosphate donor, although other nucleoside triphosphates can serve as substrates in vitro.
Product Release and Nucleotide Pool Maintenance
In simple terms: After the reaction, GDP and ADP are released to be used elsewhere in the cell.
The GDP produced by GMP kinase activity is a key precursor for GTP synthesis, which is required for DNA replication, RNA transcription, and GTP-binding protein signaling. In mitochondria, GMP kinase 1 (GUK1) provides GDP for the mitochondrial guanine nucleotide pool, supporting mtDNA replication and maintenance. Loss of GUK1 leads to mtDNA depletion and deletions, demonstrating the critical role of this activity in mitochondrial genome stability.
Role in Guanine Nucleotide Salvage
In simple terms: This enzyme recycles GMP back into the active nucleotide pool.
GMP kinase activity is a component of the guanine nucleotide salvage pathway, converting GMP derived from nucleic acid degradation or diet into GDP and GTP. This salvage is especially important in tissues with high metabolic demand, such as the brain and muscle, where de novo synthesis may be insufficient. Deficiencies in salvage enzymes like GUK1 manifest as severe mitochondrial diseases, underscoring the pathway's physiological significance.
Membrane-Associated Guanylate Kinase (MAGUK) Scaffolding
In simple terms: Some proteins with this activity also act as scaffolds that hold signaling molecules together at synapses.
The guanylate kinase domain is found in membrane-associated guanylate kinases (MAGUKs), such as PSD-95, which organize synaptic receptors and signaling complexes. Although some MAGUK guanylate kinase domains may lack catalytic activity, they serve as protein-protein interaction modules essential for synaptic development and plasticity. The enzymatic activity of GMP kinase is thus integrated into larger signaling networks at cellular junctions.
Key Genes Involved in GO:0004385 GMP kinase activity
The following genes encode proteins that possess or are associated with GMP kinase activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GUK1 | Encodes guanylate kinase 1, a cytosolic and mitochondrial enzyme that catalyzes GMP phosphorylation. | Mutations cause mitochondrial DNA depletion syndrome; target for metabolic and mitochondrial research. |
| PSD-95 (DLG4) | MAGUK scaffold protein containing a guanylate kinase-like domain; organizes synaptic signaling. | Key model for studying synaptic function and neurodevelopmental disorders. |
| MAGI1 | MAGUK family member with guanylate kinase domain; involved in cell junction signaling. | Implicated in cancer and cell polarity; potential therapeutic target. |
| CARD14 | Contains a guanylate kinase-like domain; involved in NF-kB signaling and skin inflammation. | Mutations linked to psoriasis; model for inflammatory skin diseases. |
| DLG1 | MAGUK scaffold protein with guanylate kinase domain; regulates cell polarity and proliferation. | Studied in cancer and epithelial morphogenesis. |
| DLG2 | MAGUK family member; synaptic scaffolding. | Associated with neuropsychiatric disorders. |
| DLG3 | MAGUK protein involved in synaptic organization. | Linked to intellectual disability. |
| DLGAP1 | Postsynaptic scaffold interacting with MAGUKs. | Research model for synaptic signaling. |
| GUK2 (pseudogene) | Guanylate kinase 2 pseudogene; may regulate GUK1 expression. | Pseudokinase research; potential regulatory role. |
| SRC | Kinase that regulates MAGI1-PP2A complex; indirectly affects MAGUK signaling. | Target in IDH-mutant cholangiocarcinoma. |
| PP2A | Phosphatase that interacts with MAGI1; modulates signaling. | Cancer and signaling research. |
| mTORC1 | Regulates CARD14 signalosome and keratinocyte proliferation. | Inflammatory skin disease models. |
| PALM (palmitoyl acyltransferase) | Regulates PSD-95 palmitoylation, affecting synaptic localization. | Synaptic plasticity studies. |
| ABHD17 | Depalmitoylating enzyme for PSD-95. | Regulates PSD-95 turnover. |
| Microglia (P2RY12) | Microglial protein involved in synaptic pruning. | Neurodevelopment and pruning models. |
| Gut microbiota | Modulates brain development and behavior. | Microbiome-gut-brain axis research. |
How Is GMP kinase activity Regulated?
GMP kinase activity is regulated at multiple levels. GUK1 expression and activity are influenced by cellular energy status and nucleotide demand, although specific transcriptional regulators remain to be fully defined. In the context of MAGUKs, the guanylate kinase domain can be regulated by phosphorylation and palmitoylation, which control synaptic localization and protein interactions. For example, PSD-95 palmitoylation is dynamically regulated by palmitoyl acyltransferases and depalmitoylating enzymes such as ABHD17, affecting its synaptic clustering. Additionally, CARD14 signalosome formation is associated with endosomal relocation and mTORC1-induced keratinocyte proliferation, linking GMP kinase domain-containing proteins to mTOR signaling. These regulatory mechanisms ensure that GMP kinase activity is tuned to cellular needs.
GMP kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GUK1 | Mitochondrial DNA depletion/deletions disease | Knockout and knock-in mouse models; patient-derived fibroblasts |
| DLG4 (PSD-95) | Neurodevelopmental disorders, synaptic dysfunction | Conditional knockout mice; neuronal cultures |
| MAGI1 | Cholangiocarcinoma, cell polarity | Knockout cell lines; xenograft models |
| CARD14 | Psoriasis, inflammatory skin disease | Knock-in mice; keratinocyte cultures |
| SRC | IDH-mutant cholangiocarcinoma | Patient-derived organoids; CRISPR knockout |
Mitochondrial DNA Depletion Syndrome
Biallelic mutations in GUK1, which encodes guanylate kinase 1, cause a novel mitochondrial DNA depletion/deletions disease characterized by severe neurological and muscular symptoms. This disease is potentially treatable with nucleoside supplementation, highlighting the clinical importance of GMP kinase activity. The mechanism involves impaired mitochondrial GDP supply, leading to defective mtDNA replication and maintenance.
Neurodevelopmental and Synaptic Disorders
MAGUK proteins, which contain guanylate kinase domains, are critical for synaptic organization and plasticity. Dysregulation of PSD-95 and other MAGUKs has been implicated in neurodevelopmental disorders, including autism spectrum disorders and schizophrenia. Palmitoylation cycles regulate PSD-95 synaptic clustering, and disruptions in this process are linked to synaptic dysfunction.
Cancer and Cell Signaling
MAGUK family member MAGI1 forms a growth-suppressive complex with PP2A, and its regulation by SRC kinase influences cholangiocarcinoma progression. Additionally, CARD14 signalosome formation, involving a guanylate kinase-like domain, promotes keratinocyte proliferation via mTORC1, relevant to inflammatory skin diseases and potentially cancer.
From GMP kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GUK1 loss impair mitochondrial function? | GUK1 knockout cell lines and mouse models |
| How does PSD-95 palmitoylation affect synaptic clustering? | Point mutations in palmitoylation sites; knock-in mice |
| Can GMP kinase activity be restored in GUK1 deficiency? | Knock-in of wild-type or mutant GUK1; rescue experiments |
| What is the role of MAGI1 in cancer suppression? | MAGI1 knockout and overexpression in cancer cell lines |
| How does CARD14 signalosome formation drive proliferation? | CARD14 knock-in mutations; keratinocyte models |
| Does GMP kinase activity influence gut-brain signaling? | Microbiota manipulation in knockout mice |
How to Study the GMP kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzyme assay | GMP kinase catalytic activity | Validation of GUK1 mutants |
| CRISPR knockout | Loss-of-function phenotypes | Mitochondrial DNA depletion studies |
| Knock-in mutagenesis | Effect of specific mutations | Modeling patient mutations |
| Affinity purification-MS | Protein-protein interactions | MAGUK interactome |
| Live-cell imaging | Subcellular localization | Synaptic clustering of PSD-95 |
| Palmitoylation assays | Post-translational modification | PSD-95 regulation |
| mtDNA copy number qPCR | Mitochondrial genome stability | GUK1 deficiency models |
| RNA-seq | Transcriptional changes | Pathway analysis in knockout cells |
Enzymatic Assays for GMP Kinase Activity
Direct measurement of GMP kinase activity can be performed using coupled enzyme assays that monitor ADP production or GDP formation via HPLC or spectrophotometry. These assays are essential for validating the catalytic function of GUK1 and its mutants.
CRISPR-Cas9 Knockout and Knock-in Models
CRISPR-Cas9 technology enables the generation of GUK1 knockout cell lines and knock-in models carrying patient-specific mutations, allowing researchers to study the consequences of loss or alteration of GMP kinase activity. These models are invaluable for dissecting disease mechanisms and testing therapeutic interventions.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify proteins interacting with GUK1 or MAGUKs, revealing how GMP kinase activity is integrated into cellular signaling networks. Such studies help map the guanylate kinase interactome.
Imaging and Synaptic Localization Studies
Fluorescence microscopy and live-cell imaging of tagged GUK1 or PSD-95 can reveal subcellular localization and dynamics, particularly at synapses and mitochondria. These methods are critical for understanding how GMP kinase activity is spatially regulated.
How CRISPR Can Be Used to Study GO:0004385 GMP kinase activity
Knockout
CRISPR-Cas9 knockout of GUK1 in cell lines and animal models abolishes GMP kinase activity, leading to impaired mitochondrial GDP supply and mtDNA depletion. These models are essential for studying the metabolic and mitochondrial consequences of GUK1 loss.
Point Mutation
Introducing patient-specific point mutations into GUK1 via CRISPR base editing or homology-directed repair allows researchers to dissect the impact of single amino acid changes on enzyme activity and disease phenotypes. Such models can reveal genotype-phenotype correlations.
Knock-in
Knock-in of wild-type or tagged GUK1 can rescue knockout phenotypes and enable visualization of the enzyme in live cells. This approach is useful for structure-function studies and for testing therapeutic rescue strategies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of GUK1 can elevate GMP kinase activity, allowing studies of nucleotide pool expansion and its effects on cell proliferation and signaling. Overexpression models are valuable for gain-of-function analyses.
How EDITGENE Supports GMP kinase activity Research
Researchers studying GMP kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or signaling pathway. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes associated with GO:0004385.
Contact EDITGENE today to design your custom CRISPR model for GMP kinase activity research.
Frequently Asked Questions About GMP kinase activity
What is GMP kinase activity?
GMP kinase activity (GO:0004385) is the enzymatic catalysis of the reaction ATP + GMP = ADP + GDP, transferring a phosphate group from ATP to GMP.
What genes are involved in GMP kinase activity?
The primary gene is GUK1, which encodes guanylate kinase 1. Additionally, MAGUK family genes such as DLG4 (PSD-95) contain guanylate kinase domains.
What diseases are associated with GMP kinase activity?
Mutations in GUK1 cause a mitochondrial DNA depletion/deletions disease. MAGUK dysfunction is linked to neurodevelopmental disorders.
How is GMP kinase activity regulated?
It is regulated by substrate availability, post-translational modifications like palmitoylation, and interactions with signaling complexes such as mTORC1.
What is the role of GMP kinase activity in mitochondria?
GUK1 provides GDP for mitochondrial guanine nucleotide pools, supporting mtDNA replication and stability.
Can GMP kinase activity be targeted therapeutically?
GUK1 deficiency is potentially treatable with nucleoside supplementation, and MAGUKs are considered drug targets for synaptic disorders.
What methods are used to study GMP kinase activity?
Enzymatic assays, CRISPR knockout/knock-in models, proteomics, and imaging are commonly used.
What are MAGUKs?
Membrane-associated guanylate kinases are scaffold proteins containing a guanylate kinase domain, critical for organizing synaptic signaling.
Is GMP kinase activity involved in cancer?
MAGI1, a MAGUK family member, forms a growth-suppressive complex in cholangiocarcinoma, and CARD14 signaling is linked to proliferation.
How can CRISPR help study GMP kinase activity?
CRISPR enables knockout, point mutation, knock-in, and overexpression of genes like GUK1, allowing precise functional dissection.
Conclusion
GMP kinase activity (GO:0004385) is a vital enzymatic function that maintains guanine nucleotide homeostasis and supports mitochondrial and synaptic physiology. Its emerging link to a treatable mitochondrial DNA depletion disease underscores its clinical relevance. By leveraging CRISPR-based models and EDITGENE's services, researchers can further unravel the molecular mechanisms and therapeutic potential of this activity.
References
- 1. Paolicelli RC et al.. 2011. Synaptic pruning by microglia is necessary for normal brain development.. Science 333(6048):1456-8 PMID: 21778362
- 2. Diaz Heijtz R et al.. 2011. Normal gut microbiota modulates brain development and behavior.. Proc Natl Acad Sci U S A 108(7):3047-52 PMID: 21282636
- 3. Yokoi N et al.. 2016. Identification of PSD-95 Depalmitoylating Enzymes.. J Neurosci 36(24):6431-44 PMID: 27307232
- 4. O'Sullivan PA et al.. 2024. CARD14 signalosome formation is associated with its endosomal relocation and mTORC1-induced keratinocyte proliferation.. Biochem J 481(18):1143-1171 PMID: 39145956
- 5. Kannan N et al.. 2008. Rethinking pseudokinases.. Cell 133(2):204-5 PMID: 18423189
- 6. Luk IS et al.. 2024. SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.. Sci Transl Med 16(747):eadj7685 PMID: 38748774
- 7. Gardoni F. 2008. MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse.. Eur J Pharmacol 585(1):147-52 PMID: 18367167
- 8. Hidalgo-Gutierrez A et al.. 2024. Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease.. Ann Neurol 96(6):1209-1224 PMID: 39230499
